Literature DB >> 30175588

Association Between Cognitive Tests and Antiretroviral Medication Adherence in Older Adults With HIV.

Joshua Caballero1, Raymond L Ownby2, Robin J Jacobs3, Jennifer E Thomas4, Mark S Schweizer2.   

Abstract

BACKGROUND: One of the fastest growing populations living with HIV is older adults especially those 65 years of age or older. Current antiretroviral therapy (ART) has prolonged life expectancy of persons with HIV. However, for therapy to be effective, patients need to be adherent. Over time, older persons with HIV may experience HIV-associated neurocognitive disorders or other factors that could affect ART adherence. The use of expedient cognitive tests that help measure medication adherence may be useful for the optimal care of these patients.
OBJECTIVE: To investigate the association between cognitive tests and ART adherence.
METHODS: This was a prospective study evaluating patients 65 years of age or older with HIV. Cognitive tests used included the Executive Clock-Drawing Task (CLOX) 1 and 2, Trail Making Test parts A and B, and Grooved Pegboard Test (GPB). The medication event monitoring system cap over 1 month was used as the primary measure for adherence.
RESULTS: CLOX 1 and GPB were significantly related to adherence ( P < 0.05). Comparison of the magnitude of each measure's relation to adherence suggests that the GPB is a better indicator of ability to adhere ( R = 0.514 vs R = 0.381). Conclusion and Relevance: CLOX 1 and GPB demonstrated an association with adherence in patients 65 years of age or older with HIV. Although the use of these tests to measure adherence in older persons with HIV seems promising, more research is needed to ascertain their ultimate utility.

Entities:  

Keywords:  HIV/AIDS; adherence; antiretroviral; geriatrics; mental health

Year:  2018        PMID: 30175588     DOI: 10.1177/1060028018798327

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  6 in total

1.  A Descriptive Study of HIV Patients Highly Adherent to Antiretroviral.

Authors:  Nick Williams; Craig Mayer; Vojtech Huser
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

2.  Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop.

Authors:  Asante R Kamkwalala; Ankita Garg; Upal Roy; Avery Matthews; Jose Castillo-Mancilla; Jordan E Lake; Giada Sebastiani; Michael Yin; Todd T Brown; Angela R Kamer; Douglas A Jabs; Ronald J Ellis; Marta Boffito; Meredith Greene; Sarah Schmalzle; Eugenia Siegler; Kristine M Erlandson; David J Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2021-09-20       Impact factor: 2.205

Review 3.  The Intersection of Cognitive Ability and HIV: A Review of the State of the Nursing Science.

Authors:  Drenna Waldrop; Crista Irwin; W Chance Nicholson; Cheryl A Lee; Allison Webel; Pariya L Fazeli; David E Vance
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

4.  Effects of HIV infection, antiretroviral therapy, and immune status on the speed of information processing and complex motor functions in adult Cameroonians.

Authors:  Georgette D Kanmogne; Julius Y Fonsah; Anya Umlauf; Jacob Moul; Roland F Doh; Anne M Kengne; Bin Tang; Claude T Tagny; Emilienne Nchindap; Léopoldine Kenmogne; Donald Franklin; Dora M Njamnshi; Callixte T Kuate; Dora Mbanya; Alfred K Njamnshi; Robert K Heaton
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

5.  Factors Associated with Medication Adherence for People Living with Acute HIV Infection in a Tertiary Chinese Hospital in Beijing.

Authors:  Xiaolan Wang; Dongmei Li; Meixia Gao; Yuefang Zhou; Caiping Guo; Tong Zhang; Lili Zhang; Wen Wang
Journal:  Biomed Res Int       Date:  2021-01-05       Impact factor: 3.411

6.  Impact of HIV-associated cognitive impairment on functional independence, frailty and quality of life in the modern era: a meta-analysis.

Authors:  Martins Nweke; Nombeko Mshunqane; Nalini Govender; Aderonke O Akinpelu; Maryjane Ukwuoma
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.